search

Active clinical trials for "Pulmonary Embolism"

Results 161-170 of 604

Cook IVC Filter Study

Pulmonary Embolism

This prospective, multicenter, double-arm clinical study further evaluated the safety and effectiveness of Cook's commercially available inferior vena cava (IVC) filters (specifically, the Günther Tulip® Vena Cava Filter and Cook Celect® Vena Cava Filters) in patients in need of temporary or permanent IVC filter placement for the prevention of pulmonary embolism (PE).

Completed12 enrollment criteria

Angel® Catheter Early Feasibility Clinical Study

Pulmonary EmbolismDeep Vein Thrombosis1 more

The primary objective of this clinical trial is to obtain initial insights into the safety of the Angel® Catheter in critically ill subjects with high risk of venous thromboembolism (VTE) disease AND who are not receiving pharmacological thromboprophylaxis.

Terminated31 enrollment criteria

A Safety and Efficacy Study for Implantation and Retrieval Procedures Using the VENATECH® Retrieval...

Pulmonary Thrombo-embolism

To establish the clinical safety and efficacy of the VenaTech® Retrievable Vena Cava Filter

Completed17 enrollment criteria

Hydro-mechanical Defragmentation of Pulmonary Embolism

Pulmonary Embolism

Evaluating the safety and outcomes of hydro-mechanical defragmentation of high risk pulmonary embolism with contraindication for thrombolytic therapy

Completed9 enrollment criteria

A Prospective, Multi-Center Study of the Bard® Denali™ Retrievable Inferior Vena Cava Filter System...

Pulmonary Embolism

The Bard® Denali™ Retrievable Inferior Vena Cava (IVC) study is a prospective, multi-center study which is intended to provide evidence of safety of the placement and retrieval of the Bard® Denali™ Retrievable Inferior Vena Cava Filter in subjects requiring IVC interruption to protect against pulmonary embolism (PE).

Completed19 enrollment criteria

Protection From Pulmonary Embolism With the Permanent OptEase™ Filter (PROOF)

Pulmonary Embolism

The main objective of this study is to monitor the safety and effectiveness of the OptEase™ Permanent Vena Cava (IVC) Filter

Completed9 enrollment criteria

Genotype-Guided Warfarin Therapy Trial

Atrial FibrillationDeep Vein Thrombosis2 more

The purpose of the investigators' study is to determine the clinical utility of a warfarin-dosing algorithm that incorporates genetic information (VKORC1 and CYP2C9 alleles) for adult patients initiating warfarin therapy.

Completed9 enrollment criteria

Pharmacodynamic Drug Interaction Between Warfarin and Amoxicillin-clavulanic Acid

Oral AnticoagulationDeep Venous Thrombosis2 more

Several case reports indicate that the use of the antibiotic combination amoxicillin and clavulanic acid (AM-CLAVAC) can interact with warfarin pharmacodynamics. However, fever per se might also be responsible of these warfarin overdose reports, as well as the use of high dose paracetamol. The aim of the present study is to determine if AM-CLAVAC can increase the pharmacodynamics of warfarin among patients at steady state Double blinded cross over controlled study vs placebo performed in 12 evaluable patients treated with warfarin with an INR target 2 to 3 and a stable INR and a stable dose.

Completed22 enrollment criteria

Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism

Deep Vein ThrombosisPulmonary Embolism

To investigate the efficacy and safety of once daily enoxaparin as a "bridge" to warfarin for the outpatient treatment of acute deep venous thrombosis or pulmonary embolism.

Completed22 enrollment criteria

Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism...

Pulmonary Embolism

This is a multicenter, randomized, open-label, assessor-blind, event-driven, non-inferiority program for efficacy with a study treatment duration of 3, 6 or 12 months in patients with confirmed acute symptomatic pulmonary embolism (PE) with or without symptomatic Deep-Vein Thrombosis (DVT) (Einstein-PE).

Completed5 enrollment criteria
1...161718...61

Need Help? Contact our team!


We'll reach out to this number within 24 hrs